Notably, in colon cancer, Mkp-1 was overexpressed in the early phases of carcinogenesis [15, 16], and it impaired the response to cetuximab-based treatment in patients with metastatic colon cancer [17]. The gene discussed is DUSP1; the disease is malignant colon neoplasm.